Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Profit Margin (Quarterly): -8.16K% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -8.16K% |
| March 31, 2023 | -5.46K% |
| December 31, 2022 | -2.02K% |
| September 30, 2022 | |
| June 30, 2022 | -3.78K% |
| March 31, 2022 | |
| December 31, 2021 | -3.88K% |
| September 30, 2021 | |
| June 30, 2021 | -128.2K% |
| March 31, 2021 | -9.65K% |
| December 31, 2020 | -13.99K% |
| September 30, 2020 | -11.43K% |
| June 30, 2020 | -77.11K% |
| March 31, 2020 | -13.54K% |
| December 31, 2019 | |
| September 30, 2019 | -3.58K% |
| June 30, 2019 | -17.55K% |
| March 31, 2019 | -1.24K% |
| December 31, 2018 | |
| September 30, 2018 | -230.9% |
| June 30, 2018 | -160.1% |
| March 31, 2018 | -737.9% |
| December 31, 2017 | |
| September 30, 2017 | -64.67% |
| June 30, 2017 | -815.5% |
| Date | Value |
|---|---|
| March 31, 2017 | -542.5% |
| December 31, 2016 | -907.5% |
| September 30, 2016 | -684.2% |
| June 30, 2016 | -678.3% |
| March 31, 2016 | -296.8% |
| December 31, 2015 | -75.88% |
| September 30, 2015 | -163.0% |
| June 30, 2015 | -423.8% |
| March 31, 2015 | -983.8% |
| December 31, 2014 | 87.45% |
| September 30, 2014 | -832.8% |
| June 30, 2014 | |
| March 31, 2014 | -138.8% |
| December 31, 2013 | -138.0% |
| September 30, 2013 | -88.20% |
| June 30, 2013 | -47.47% |
| March 31, 2013 | -39.84% |
| December 31, 2012 | 14.19% |
| September 30, 2012 | 32.33% |
| June 30, 2012 | 12.73% |
| March 31, 2012 | -397.2% |
| December 31, 2011 | 42.11% |
| September 30, 2011 | -58.52% |
| June 30, 2011 | -54.93% |
| March 31, 2011 | -88.50% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-128.2K%
Minimum
Jun 2021
-2.02K%
Maximum
Dec 2022
-22.95K%
Average
-9.65K%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.92% |
| Return on Assets | 2.45% |
| Return on Invested Capital | 4.20% |
| Operating Margin (Quarterly) | -8.04K% |
| Return on Net Operating Assets | 6.12% |